What is he best known for?
The fields of study he is best known for:
- Immune system
- Internal medicine
- Tuberculosis
His scientific interests lie mostly in Immunology, Tuberculosis, Mycobacterium tuberculosis, Virology and Vaccination.
All of his Immunology and Immune system and Cellular immunity investigations are sub-components of the entire Immunology study.
His work in Immune system addresses issues such as Antigen, which are connected to fields such as Interferon gamma.
His study in Tuberculosis is interdisciplinary in nature, drawing from both Disease and Intensive care medicine.
The Virology study combines topics in areas such as ESAT-6 and Immunity.
His Vaccination study combines topics from a wide range of disciplines, such as Tuberculosis vaccines, Adjuvant and Immunization.
His most cited work include:
- The success and failure of BCG - implications for a novel tuberculosis vaccine. (561 citations)
- Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice (358 citations)
- Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. (254 citations)
What are the main themes of his work throughout his whole career to date?
T. Mark Doherty mostly deals with Immunology, Tuberculosis, Mycobacterium tuberculosis, Virology and Vaccination.
He has included themes like Latent tuberculosis and ESAT-6 in his Immunology study.
His Tuberculosis research is multidisciplinary, incorporating elements of Disease, Incidence and Immunity.
His study looks at the intersection of Mycobacterium tuberculosis and topics like Asymptomatic with Sputum.
T. Mark Doherty combines subjects such as Protein subunit, Subunit vaccines, Immunodominance and Clinical trial with his study of Virology.
His research in Vaccination intersects with topics in Adjuvant, Mycobacterium bovis, Immunization and Gerontology.
He most often published in these fields:
- Immunology (72.73%)
- Tuberculosis (72.73%)
- Mycobacterium tuberculosis (56.82%)
What were the highlights of his more recent work (between 2016-2020)?
- Vaccination (37.50%)
- Gerontology (5.68%)
- Tuberculosis (72.73%)
In recent papers he was focusing on the following fields of study:
T. Mark Doherty focuses on Vaccination, Gerontology, Tuberculosis, Internal medicine and Psychological intervention.
His research integrates issues of Infectious disease, Disease, Antimicrobial and Immune system in his study of Vaccination.
His Immune system study is related to the wider topic of Immunology.
Preventive healthcare, Influenza vaccine and Demographic change is closely connected to Population ageing in his research, which is encompassed under the umbrella topic of Gerontology.
He interconnects Disease cluster, Incidence and Pneumonia in the investigation of issues within Tuberculosis.
His Antigen research includes elements of Clinical trial, Pharmacovigilance and Virology.
Between 2016 and 2020, his most popular works were:
- Maternal immunization: where are we now and how to move forward? (44 citations)
- Fighting against a protean enemy: immunosenescence, vaccines, and healthy aging. (42 citations)
- Safety of AS03-adjuvanted influenza vaccines: A review of the evidence. (31 citations)
In his most recent research, the most cited papers focused on:
- Immune system
- Internal medicine
- Antibody
T. Mark Doherty mainly investigates Vaccination, Gerontology, Psychological intervention, Infectious disease and Value.
His Gerontology study combines topics in areas such as Translational research and Immunosenescence, Immune system.
His studies deal with areas such as Obstetrics, Tetanus and Immunity, Passive immunity as well as Infectious disease.
Many of his Value research pursuits overlap with Immunization, Developed country and Vaccine-preventable diseases.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
